Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tisseel for Pain Reduction in Cleft Palate Surgery
NCT02953145Phase 4Withdrawn
- Sponsor
- University of Alberta
- Start
- Sep 2019
- Primary completion
- Sep 2020
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tisseel in cleft palate (2 arms), sponsored by University of Alberta. Primary endpoint: Post operative pain (FLACC score) at 72 hours. Planned start Sep 2019; status: withdrawn.
02
Drugs
tisseel
03
Conditions
cleft palate
Beyond the preview
Go deeper on NCT02953145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953145.